Internal Medicine, Phoenix

Medicine & Life Sciences

1. Coccidioidomycosis 100%
2. Endothelial Cells 95%
3. Lung 93%
4. Coccidioides 64%
5. Hepatopulmonary Syndrome 61%
6. Acute Lung Injury 46%
7. sphingosine 1-phosphate 44%
8. Myosin-Light-Chain Kinase 44%
9. Thrombin 33%
10. Phosphorylation 26%
11. Endothelium 26%
12. Blood Vessels 25%
13. Lung Injury 23%
14. Fibrosis 23%
15. Nicotinamide Phosphoribosyltransferase 22%
16. Infections 22%
17. Liver Transplantation 21%
18. Permeability 20%
19. Genes 20%
20. Sphingosine-1-Phosphate Receptors 20%
21. Pulmonary Artery 19%
22. Adult Respiratory Distress Syndrome 19%
23. Bronchoalveolar Lavage 19%
24. Idiopathic Pulmonary Fibrosis 18%
25. Cortactin 17%
26. Ventilator-Induced Lung Injury 17%
27. Pulmonary Hypertension 16%
28. Therapeutics 16%
29. Liver Diseases 15%
30. Antigens 15%
31. Proteins 15%
32. Ketoconazole 15%
33. Capillary Permeability 15%
34. Actins 15%
35. Myosin Light Chains 14%
36. Sarcoidosis 14%
37. Mortality 13%
38. Protein Isoforms 13%
39. In Vitro Techniques 12%
40. Lung Diseases 12%
41. Pulmonary Arterial Hypertension 12%
42. Neutrophils 12%
43. Protein Kinase C 12%
44. Fluconazole 12%
45. Mechanical Stress 12%
46. Single Nucleotide Polymorphism 11%
47. Mycoses 11%
48. Biomarkers 11%
49. Hypoxia 11%
50. Cattle 11%
51. Ligation 11%
52. Sepsis 11%
53. Amphotericin B 10%
54. HIV 10%
55. Fingolimod Hydrochloride 10%
56. Survival 10%
57. Pneumonia 10%
58. Histoplasmosis 10%
59. Phospholipase D 9%
60. Liver 9%
61. Common Bile Duct 9%
62. Phosphotransferases 9%
63. Tyrosine 9%
64. Focal Adhesions 9%
65. Electric Impedance 9%
66. Serum 9%
67. Bronchoalveolar Lavage Fluid 9%
68. Inflammation 9%
69. Gene Expression 9%
70. Cytoskeleton 9%
71. Fungi 9%
72. diperoxovanadate 8%
73. Yeasts 8%
74. Simvastatin 8%
75. Interstitial Lung Diseases 8%
76. Population 7%
77. Endothelin-1 7%
78. p38 Mitogen-Activated Protein Kinases 7%
79. Albumins 7%
80. Antibodies 7%
81. End Stage Liver Disease 7%
82. Portal Hypertension 7%
83. Reactive Oxygen Species 7%
84. Small Interfering RNA 7%
85. Pharmaceutical Preparations 7%
86. Stress Fibers 7%
87. Lipopolysaccharides 7%
88. Cytokines 7%
89. Hypertension 7%
90. Meningitis 7%
91. Flucytosine 6%
92. Mexican Americans 6%
93. Nitric Oxide Synthase Type III 6%
94. Microtubules 6%
95. African Americans 6%
96. Vasodilation 6%
97. Pulmonary Fibrosis 6%
98. Signal Transduction 6%
99. Growth 6%
100. Hispanic Americans 6%